SuchitraSundaramMD

PubMed

• 233 citations
  Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study.
  Anthony R. Mato, Nirav N. Shah, Wojciech Jurczak, Chan Yoon Cheah, John M. Pagel
  Lancet. 2021-03-06
• 26 citations
  Outcomes of patients with limited-stage aggressive large B-cell lymphoma with high-risk cytogenetics.
  Pallawi Torka, Shalin Kothari, Suchitra Sundaram, Shaoying Li, L. Jeffrey Medeiros
  Blood Advances. 2020-01-28
• 48 citations
  COVID-19 in patients with CLL: improved survival outcomes and update on management strategies.
  Lindsey E. Roeker, Toby A. Eyre, Meghan C. Thompson, Nicole Lamanna, Alexander Coltoff
  Blood. 2021-07-23

Abstracts/Posters

• Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-Worl...
  Suchitra Sundaram, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Outcomes of Patients with Refractory Peripheral T-Cell Lymphoma, Angioimmunoblastic and Other Nodal Lymphomas of T Follicular Helper-Cell Origin (OPerA)
  Suchitra Sundaram, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)
  Suchitra Sundaram, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• Utility of Bone Marrow Biopsy in the Staging of T-Cell Lymphoma in the PET-CT Era 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Early Complete Remission By Functional Imaging and Intensified Frontline Therapy Are Associated with an Improved Clinical Outcome in Patients with Newly Diagnosed T-Ce... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019